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Diarrhoea is a major cause of morbidity and mortality in young children. This study aimed to 
investigate the gut microbiome of under-five diarrhoeic children in Lagos and Ogun States. 
Hospital records were obtained from the four healthcare facilities used. Ethical approval was 
obtained from two tertiary institutions. A total of 180 stool samples were taken from under-
five diarrhoeic and non-diarrhoeic children from two states in approximately a ratio of four to 
one (4:1). Samples were analysed using standard, cultural and biochemical techniques. Isolates 
were further identified using the API 20E test. An Antibiogram profile of the pure isolates was 
conducted using the disks diffusion technique. Amplicon-based metagenomic analyses were 
carried out on DNA isolates obtained from stool samples of diarrhoeic and healthy children. 
The species richness and species abundance were determined using the Microbial Genomics 
Module version 4.0 (Qiagen). Data obtained from the questionnaires, hospital records, and 
antibiogram were analysed using logistic regression, Chi-square and student t-tests. This study 
showed an overall prevalence rate of 11.1% for diarrhoea in Lagos and Ogun States. Mother’s 
educational status (OR= 11.459, P= 0.0001), mother’s employment status (OR= 2.082, P= 
0.025) and family income (OR= 7.613, P=0.0001), were the factors significantly associated 
with diarrhoea. A total of 279 isolates obtained were predominantly members of the 
Enterobacteriaceae. Others include Pseudomonas, Staphylococcus, Bacillus, Acinetobacter, 
and Alcaligenes.  Most of the bacteria isolated from the diarrhoeic children were resistant to 
multiple class of antibiotics; Penicillins, Sulonamides, Tetracyclines, and Cefuroxime in a 
decreasing order. The isolates were more resistant to Ampicillin (83.4%), Augmentin (79.6%), 
Trimethoprim-Sulphamethoxazole 70.5%), and Tetracycline (65.6%) and more sensitive to 
Nitrofurantoin (68.9%), Gentamycin 67.2%), Ofloxacin (65.9%), and Ciprofloxacin (61.8%). 
The phylogenetic diversity revealed six bacterial phyla which include Firmicutes (51.7%), 
Bacteroidetes (9.1%), Proteobacteria (27.1%), Actinobacteria (11.5%), Fusobacteria (0.5%), 
and Verrucomicrobia (0.1%). The major classes in the Firmicutes were Bacilli (71%) and 
Clostridia 24%. The classes under Proteobacteria were mainly Gammaproteobacteria (99.9%) 
while Alphaproteobacteria occurred (0.1%). The two classes, Actinobacteria (50%) and 
Coriobacteriia (50%), in the phylum Actinobacteria, were represented equally. The phyla 
Bacteroidetes, Fusobacteria and Verrucomicrobia were represented by a single class each 
which is: Bacteroidia (100%), Fusobacteriia (100%) and Verrucomicrobiae (100%), 
respectively. The predominant phyla detected among the diarrhoeic samples were Firmicutes 
(50.4%) and Proteobacteria (37.2%). There was a remarkable increase in the abundance of 
Proteobacteria in the diarrhoeic group (37.2%), compared to the healthy group (6.5%) at 
p<0.0001. The total number of different species presented decreased in the diarrhoeic children 
(341, 31%) and increased in the non-diarrhoeic children (774, 69%). Also, the proportion of 
Escherichia coli, Shigella, Staphylococcus and Klebsiella were in abundance in the diarrhoeic 
group. In contrast, Bifidobacterium, Faecalibacterium, Lactobacillus, Clostridium (sensu 
stricto), and Bacteroides significantly decreased in the diarrhoeic group. This suggests that 
diarrhoeal diseases thrive in the dysbiotic gut, which is characterised by the depletion of 
beneficial microbes and increased pathogens in the gut.  
 
Keywords: Bacteria, Children, Diarrhoea, Gut Microbiome, Metagenome
